James Metz, MD
OncoLink Associate Editor
Last Modified: November 1, 2001
Presenter: Sanford L. Meeks, MD
Affiliation: University of Iowa
Confirmation of accurate patient positioning is paramount in treatment of tumors utilizing stereotactic radiotherapy. Typically, invasive head rings are used for the treatment of many patients with CNS disease. The University of Florida has utilized infrared emitting diodes since 1995 for localization with stereotactic radiotherapy. This presentation evaluates the feasibility of utilizing a system that does not require an invasive head frame. This system utilizes optical guidance for stereotactic radiotherapy with infrared emitting diodes to determing the position of the patient in relation to the accelerator.
ASTRO coverage is sponsored, in part, by Varian Medical Systems, Inc.
Jul 1, 2014 - Use of multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging (MP 18FDG PET-MRI) using dynamic contrast-enhanced MRI, diffusion-weighted imaging, three-dimensional proton MR spectroscopic imaging, and 18FDG-PET can improve differentiation of benign and malignant breast tumors, according to a study published online June 24 in Clinical Cancer Research.
Apr 28, 2010
Jul 23, 2014